{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:59:51Z","timestamp":1790200791741,"version":"4.1.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jceh.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T02:29:25Z","timestamp":1657592965000},"page":"350-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Post-Transplant Immunosuppression in Autoimmune Liver Disease"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-9597","authenticated-orcid":false,"given":"Claire","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Heneghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.07.002_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","author":"Ilyas","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib3","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/lt.23704","article-title":"Liver transplantation and autoimmune liver diseases","volume":"19","author":"Liberal","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib4","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.07.002_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MCG.0000000000001271","article-title":"Increased posttransplant mortality for autoimmune hepatitis compared with other autoimmune liver diseases","volume":"54","author":"Lee","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/liv.14248","article-title":"Long-term outcomes after liver transplantation in the Hispanic population","volume":"40","author":"Ochoa-Allemant","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/ajt.16864","article-title":"Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European Liver Transplant Registry","volume":"22","author":"Heinemann","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.jceh.2022.07.002_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib15","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.07.002_bib16","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib17","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3748\/wjg.14.3388","article-title":"Transplantation in autoimmune liver diseases","volume":"14","author":"Mottershead","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transplant"},{"issue":"4 Pt 1","key":"10.1016\/j.jceh.2022.07.002_bib19","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2000.19149","article-title":"Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self","volume":"32","author":"Manns","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1046\/j.1440-1746.2001.02646.x","article-title":"Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women","volume":"16","author":"Lee","year":"2001","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib21","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s10620-017-4675-y","article-title":"Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis","volume":"62","author":"Czaja","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.07.002_bib22","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib23","first-page":"971","article-title":"European association for the study of the, L","volume":"63","year":"2015","journal-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib25","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.transproceed.2007.07.023","article-title":"Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list","volume":"39","author":"Ferraz-Neto","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.07.002_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1478-3231.2005.01121.x","article-title":"Early treatment response predicts the need for liver transplantation in autoimmune hepatitis","volume":"25","author":"Tan","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/lt.24462","article-title":"Liver transplantation in the United Kingdom","volume":"22","author":"Neuberger","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib28","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib29","article-title":"Mortality on the UNOS waitlist for patients with autoimmune liver disease","volume":"9","author":"Suri","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jceh.2022.07.002_bib30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5009\/gnl19261","article-title":"Autoimmune hepatitis: 2019 update","volume":"14","author":"Tanaka","year":"2020","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2022.07.002_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lt.25375","article-title":"Recurrent and de novo autoimmune hepatitis","volume":"25","author":"Stirnimann","year":"2019","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/TP.0b013e31821841ba","article-title":"The pattern of late mortality in liver transplant recipients in the United Kingdom","volume":"91","author":"Gelson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1477-2574.2010.00162.x","article-title":"Liver retransplantation in adults: a single-centre, 25-year experience","volume":"12","author":"Marudanayagam","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jceh.2022.07.002_bib35","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","author":"Gautam","year":"2006","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib36","article-title":"Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies","volume":"2019","author":"Sucher","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jceh.2022.07.002_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/liv.14062","article-title":"Autoimmune hepatitis: current and future therapeutic options","volume":"39","author":"Doycheva","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12936","article-title":"Histologic surveillance after liver transplantation due to autoimmune hepatitis","volume":"31","author":"Puustinen","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib39","first-page":"137","article-title":"Single-Center North American experience of liver transplantation in autoimmune hepatitis: infrequent indication but good outcomes for patients","volume":"4","author":"de Quadros Onofrio","year":"2021","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-001-0213-2","article-title":"Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence","volume":"26","author":"Renz","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.jceh.2022.07.002_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A\u00a010 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.002_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2022.01.022","article-title":"Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation","volume":"77","author":"Montano-Loza","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib45","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"D'Antiga","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.31407","article-title":"Immunosuppressive treatment regimens in autoimmune hepatitis: systematic reviews and meta-analyses supporting American association for the study of liver diseases guidelines","volume":"72","author":"Vierling","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2005.12.010","article-title":"Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study","volume":"44","author":"Llado","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib51","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"issue":"4 Pt 1","key":"10.1016\/j.jceh.2022.07.002_bib53","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib55","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1600-6143.2010.03080.x","article-title":"Phenotypic expression of recurrent disease after liver transplantation","volume":"10","author":"O'Grady","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib56","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a\u00a0single-center experience","volume":"39","author":"Khalaf","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.07.002_bib57","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16023","article-title":"Review article: pathophysiology and management of primary biliary cholangitis","volume":"52","author":"Leung","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.07.002_bib58","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2017.10.018","article-title":"Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2022.07.002_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12016-019-08772-7","article-title":"Clinical management of primary biliary cholangitis-strategies and evolving trends","volume":"59","author":"Gao","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jceh.2022.07.002_bib61","first-page":"145","article-title":"A\u00a0practical review of primary biliary cholangitis for the gastroenterologist","volume":"15","author":"Onofrio","year":"2019","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jceh.2022.07.002_bib62","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib63","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cld.2018.03.011","article-title":"Current status of liver transplantation for primary biliary cholangitis","volume":"22","author":"Aguilar","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib64","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib65","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib66","first-page":"49","article-title":"Clinical updates in primary biliary cholangitis: trends, epidemiology, diagnostics, and new therapeutic approaches","volume":"8","author":"Galoosian","year":"2020","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib67","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jceh.2022.07.002_bib68","article-title":"Risk factors for recurrent autoimmune liver diseases after liver transplantation: a meta-analysis","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2022.07.002_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib72","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00007890-200008150-00014","article-title":"Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors","volume":"70","author":"Milkiewicz","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0012.2007.00788.x","article-title":"Late acute rejection after liver transplantation impacts patient survival","volume":"22","author":"Uemura","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib74","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid","volume":"3","author":"Satapathy","year":"2017","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jceh.2022.07.002_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib76","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transplant Surg"},{"key":"10.1016\/j.jceh.2022.07.002_bib77","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib78","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib79","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib80","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","article-title":"Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"24","author":"Van de Water","year":"1996","journal-title":"Hepatology"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2022.07.002_bib81","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpg.2018.09.001","article-title":"PBC-transplantation and disease recurrence","volume":"34\u201335","author":"Nevens","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib83","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.002_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2022.07.002_bib85","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib86","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.21624","article-title":"Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis","volume":"45","author":"Robertson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib87","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(05)80206-5","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression","volume":"17","author":"Wong","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","volume":"63","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib91","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mpmed.2019.09.004","article-title":"Primary sclerosing cholangitis","volume":"47","author":"Chapman","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2022.07.002_bib92","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.07.002_bib93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib94","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.jceh.2022.07.002_bib96","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient Age, sex, and inflammatory bowel disease phenotype Associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.07.002_bib97","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/lt.25838","article-title":"Impact of preexisting inflammatory bowel disease on the outcome of liver transplantation for primary sclerosing cholangitis","volume":"26","author":"Irles-Depe","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib98","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","article-title":"An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort","volume":"55","author":"Bakhshi","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib99","first-page":"293","article-title":"Primary sclerosing cholangitis, Part 1: epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jceh.2022.07.002_bib100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0041-1345(03)00064-2","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"35","author":"Salguero","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.07.002_bib101","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/bega.2001.0212","article-title":"Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease","volume":"15","author":"Wiesner","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib102","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00535-020-01681-z","article-title":"Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities","volume":"55","author":"Vesterhus","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib103","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEG.S105872","article-title":"Primary sclerosing cholangitis: diagnostic and management challenges","volume":"10","author":"Sirpal","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jceh.2020.06.004","article-title":"Ethnicity-specific differences in liver transplant outcomes among adults with primary sclerosing cholangitis: 2005-2017 united Network for organ sharing\/organ procurement and transplantation Network","volume":"11","author":"Bayable","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib106","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/lt.24703","article-title":"Outcomes of liver retransplantation in patients with primary sclerosing cholangitis","volume":"23","author":"Henson","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib107","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.07.002_bib108","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib109","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic\u00a0Multicentre Study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0037-1608655","article-title":"Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis","volume":"37","author":"Martin","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib111","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib112","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2022.07.002_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib114","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jceh.2022.07.002_bib116","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","author":"Egawa","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2022.07.002_bib117","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jceh.2022.07.002_bib118","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transplant"},{"issue":"suppl 2","key":"10.1016\/j.jceh.2022.07.002_bib119","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/lt.23742","article-title":"Systematic investigation of elevated cholestatic enzymes during the third posttransplant month","volume":"19","author":"Mason","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib120","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A\u00a0re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00365520500206293","article-title":"Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection","volume":"41","author":"Verdonk","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib123","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/lt.24490","article-title":"Recurrence of autoimmune\u00a0liver disease and inflammatory bowel disease after pediatric liver transplantation","volume":"22","author":"Liberal","year":"2016","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib124","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1089-3261(05)70167-7","article-title":"Autoimmune liver disease. Current standards, future directions","volume":"5","author":"Gish","year":"2001","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib127","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib128","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib129","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-200103150-00016","article-title":"De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation","volume":"71","author":"Gupta","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.TP.0000132328.33460.43","article-title":"Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation","volume":"78","author":"Miyagawa-Hayashino","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib131","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience","volume":"43","author":"Cho","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2022.07.002_bib132","first-page":"131","article-title":"Autoimmune hepatitis as a late complication of liver transplantation","volume":"32","author":"Hernandez","year":"2001","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jceh.2022.07.002_bib133","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2022.07.002_bib134","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2012.02832.x","article-title":"Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation","volume":"32","author":"Montano-Loza","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.07.002_bib135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib136","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.07.002_bib137","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?","volume":"56","author":"Berardi","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2022.07.002_bib138","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.dld.2014.03.002","article-title":"De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency","volume":"46","author":"Aguilera","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jceh.2022.07.002_bib139","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/TP.0b013e31829eda7f","article-title":"Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults","volume":"96","author":"Sebagh","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2022.07.002_bib140","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jceh.2022.07.002_bib141","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2011.10.007","article-title":"Autoimmune liver diseases in children - what is different from adulthood?","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2022.07.002_bib142","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.08.004","article-title":"Autoimmune hepatitis: contrasts and comparisons in children and adults - a comprehensive review","volume":"46","author":"Floreani","year":"2013","journal-title":"J\u00a0Autoimmun"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:10:01Z","timestamp":1760854201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0973688322001670"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.07.002","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transplant Immunosuppression in Autoimmune Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}